Trump: Thermo Fisher investing $2 billion in Ohio
The White House announced that Thermo Fisher Scientific, a leading biotechnology company, has pledged an additional $2 billion over the next four years to enhance and expand its U.S.-based manufacturing operations, aligning with President Donald Trump’s “America First” economic agenda according to White House announcements. This investment is part of a broader surge in domestic corporate spending, with the administration highlighting over $4 trillion in new U.S. commitments since the start of Trump’s first term.
Thermo Fisher’s expansion aims to strengthen domestic production capacity and innovation, supporting the administration’s focus on revitalizing American manufacturing. The company’s investment follows similar pledges from major corporations, including Apple ($600 billion), Meta ($600 billion), and NVIDIA ($500 billion), all emphasizing U.S. infrastructure, workforce development, and advanced technology sectors.
The White House cited these investments as evidence of Trump’s economic policies driving industrial growth and job creation, with an estimated 149,000 permanent jobs and 12,000 construction jobs projected across the announced projects according to investment reports. Foreign and domestic firms, including Japan’s SoftBank, Saudi Arabia’s energy sector, and U.S.-based pharmaceutical companies, have also contributed to the investment wave as detailed in White House analysis.
Thermo Fisher’s announcement coincides with Trump’s scheduled visit to its Ohio facility, where he will highlight initiatives such as the “Trump RX” program to reduce drug costs as reported by local news outlets. The administration attributes the momentum to tax reforms, regulatory streamlining, and trade policies prioritizing domestic production.
While the scale of these commitments reflects strong corporate confidence, analysts note that execution and long-term economic impacts will depend on factors such as supply chain resilience, labor availability, and global market dynamics according to economic analysis.


Comentarios
Aún no hay comentarios